2016

Oral activated charcoal effectively delays the onset of hyperphosphatemia in patients with chronic kidney disease. OAC appears to delay the development of vascular calcifications in stage 3-4 CKD patients.

Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.Development ...

The developed method enabled estimation of the amplitude of DDI by activated charcoal administered in a certain dosing interval, whereas overestimation of AUCRe was observed for drugs that undergo extensive enterohepatic circulation.

Chronic kidney disease (CKD) is a non-reversible and progressive disease affecting the kidneys, significantly impacting global public health. One of the complications of chronic kidney disease is impaired intestinal barrier function, which may allow harmful ...

(NaturalNews365) A new study published in eBioMedicine reveals that 80% of analyzed blood clots contained microplastics.

(NaturalHealth365) One in 7 American adults has chronic kidney disease. Activated charcoal helps reduce associated toxins and waste in blood.

(NaturalHealth365) Glyphosate, Bayer's toxic herbicide, faces scrutiny over health concerns and alleged corporate cover-ups.

--- Other Channels You May Enjoyhttps://www.youtube.com/@bad-sad https://www.youtube.com/@Cothfotmeoo https://www.youtube.com/@Dunstan3 https://www.youtub...

Is the EXACT year of Jesus' return hidden in the Book of Daniel? (Not day or hour). The ancient Hebrew calendar and method for telling time is the secret to ...

In this June 28, 2024 interview, Brian Holthaus welcomes Bill Salus to share from his expansive body of work as it relates to end time biblical prophecies, e...

A popular video says that Jesus is returning in 2027 because Christians missed a decree in Daniel's 70 Weeks which marked the start of the prophecy. The dec...

The "BIBLE NEWSPAPER" that examines current events through the prophetic lens

In the wake of the catastrophic Presidential debate in June, concerns over Biden’s mental health have been seriously questioned by Democrats and Republicans alike. While new details from a leading Neurologist strongly suggest a Parkinson’s diagnosis, could the President actually be suffering from a neurodegenerative disorder related to vaccine injury? The HighWire delves into the […]

(NaturalHealth365) Over 42,000 women died of breast cancer in 2020 alone. New research shows medicinal mushrooms may help combat the disease.

(NaturalHealth365) Studies reveal how chemotherapy can threaten family members and healthcare workers. Find out how to avoid contamination.

(NaturalHealth365) Discover how everyday cleaning products and flame retardants may harm brain health, affecting memory and cognition.

(NaturalHealth365) Taking statins to lower your cholesterol can produce deadly results. Find out what your doctor may not tell you.

3000 years ago, the Prophet Joel was given a prophecy that the nation of Israel would be divided into a Two-State Solution right before the return of Jesus. ...

From its institution as a nation, the hope of Israel was never found within the people themselves. The foundation of their hope was - and is to this day - so...

Christians miss the MOST TRUSTWORTHY signs of Jesus' return and concentrate on ones that aren't Biblically certain or easily identifiable. This is a PROBLEM....

We are beginning to see what the impact of the terrorist group Hezbollah will be in the near future. Does this dangerous Iranian proxy exist in Bible prophec...

In this timely Q & A program, Gary Stearman asks Dr. Bill Salus to share his expertise on Bible prophecy as it pertains to the Promised Land. Gary and Bill d...

(NaturalHealth365) Discover how garlic can revolutionize health by combating diabetes, hypertension, obesity, and cardiovascular diseases.

Trehalose (α-d-glucopyranosyl-(1-1)-α-D-glucopyranoside) has found applications in diverse food products as a sweetener, stabilizer, and humectant. Recent attention has focused on trehalose due to its contradictory effects on the virulence of Clostridium difficile. In this study, we investigate the …

ackground: Lung cancer, the most commonly diagnosed cancer globally, has the highest incidence and mortality rates in Taiwan. It can be divided into two types. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancers, which is further divided into adenocarcinoma, squamous cell carcinoma, and large cell lung cancer accounting for approximately 40%, 25%, and 15% of NSCLC cases, respectively. Small cell lung cancer accounts for approximately 15% of lung cancers. Early systemic therapy NSCLC was based on chemotherapy, and immunotherapy is currently under development. Fucoidan, from brown seaweed extracts, shows promise in mitigating radiation-induced lung fibrosis in animal studies, suggesting its potential as an adjuvant for radiation therapy-related lung fibrosis in lung cancer patients. However, the clinical utility of such adjuvant therapy in lung cancer treatment remains uncertain. The purpose of this study was to investigate the effects of oral administration of oligo-fucoidan on the survival rate, quality of life, and immunity of patients with lung cancer. Methods: Subjects with Non-small cell lung cancer aged between 20 and 80 were collected from outpatient clinics, divided into control group (n = 7): conventional therapy and fucoidan group (n = 13): received conventional therapy+ oral supplementation of oligo-fucoidan (550 mg × 4 tablets). Data were collected before the study, at weeks 4, 12, and 24 during the study, and to collect 20 ml of peripheral blood, for analysis biochemical data, liver and kidney function, lymphocyte population, inflammation cytokines, and using EORTC QLQ-C30 questionnaire to assess quality of life. Results: The survival rates of the subjects in the control and fucoidan groups were 20% and 28.6%, respectively. During the study, patients in the fucoidan group experienced a better quality of life than those in the control group, but this difference lacked statistical significance. Oligo-fucoidan increases the CD19 lymphocyte population. The patients in the fucoidan group also had Lower inflammatory cytokine. Conclusion: Oligo-fucoidan holds promise as an adjuvant therapy to enhance the survival rate, quality of life, and immune function in patients with lung cancer.